NCT00545025View on ClinicalTrials.gov

Revaccination With Influenza Vaccine GSK1247446A

PHASE2CompletedINTERVENTIONAL
Enrollment

243

Participants

Timeline

Start Date

October 15, 2007

Primary Completion Date

December 12, 2007

Study Completion Date

December 12, 2007

Conditions
InfluenzaInfluenza, Human
Interventions
BIOLOGICAL

Influenza Vaccine GSK1247446A

Single dose, Intramuscular injection

BIOLOGICAL

Fluarix™

Single dose, Intramuscular injection

Trial Locations (1)

2610

GSK Investigational Site, Wilrijk

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00545025 - Revaccination With Influenza Vaccine GSK1247446A | Biotech Hunter | Biotech Hunter